TORRENT PHARM revenue breakdown overview

TORRENT PHARM revenue for the last year amounted to 96.20 B INR, the most of which — 96.20 B INR — came from its highest performing source at the moment, Generic Formulation, the year earlier bringing 85.08 B INR. The greatest contribution to the revenue figure was made by India — last year it brought TORRENT PHARM 53.70 B INR, and the year before that — 46.83 B INR.